Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R O Dillman

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Antibodies as cytotoxic therapyR O Dillman
Cancer Biotherapy|January 1, 1994
The clinical experience with interleukin-2 in cancer therapyR O Dillman
Annals of Internal Medicine|October 1, 1989
Monoclonal antibodies for treating cancerR O Dillman
Clinical and Experimental Medicine|March 22, 2006
Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodiesR O Dillman
Cancer Practice|March 7, 2002
Monoclonal antibody therapy for lymphoma: an updateR O Dillman
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Perceptions of Herceptin: a monoclonal antibody for the treatment of breast cancerR O Dillman
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
What to do with IL-2?R O Dillman
Cancer Biotherapy & Radiopharmaceuticals|August 1, 1997
Magic bullets at last! Finally--approval of a monoclonal antibody for the treatment of cancer!!!R O Dillman
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1996
Why event-free survival is better than tumor response or other measures of survival as an endpoint in cancer trialsR O Dillman
Cancer Metastasis Reviews|June 16, 2000
Infusion reactions associated with the therapeutic use of monoclonal antibodies in the treatment of malignancyR O Dillman
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1994
Antibodies as cytotoxic therapyR O Dillman
Cancer Biotherapy|January 1, 1994
The clinical experience with interleukin-2 in cancer therapyR O Dillman
Annals of Internal Medicine|October 1, 1989
Monoclonal antibodies for treating cancerR O Dillman
Clinical and Experimental Medicine|March 22, 2006
Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodiesR O Dillman
Cancer Practice|March 7, 2002
Monoclonal antibody therapy for lymphoma: an updateR O Dillman
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Perceptions of Herceptin: a monoclonal antibody for the treatment of breast cancerR O Dillman
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
What to do with IL-2?R O Dillman
Cancer Biotherapy & Radiopharmaceuticals|August 1, 1997
Magic bullets at last! Finally--approval of a monoclonal antibody for the treatment of cancer!!!R O Dillman
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1996
Why event-free survival is better than tumor response or other measures of survival as an endpoint in cancer trialsR O Dillman
Cancer Metastasis Reviews|June 16, 2000
Infusion reactions associated with the therapeutic use of monoclonal antibodies in the treatment of malignancyR O Dillman
Pageof 14